ATTBF
Healthcare Drug Manufacturers - Specialty & GenericAbattis Bioceuticals Corp.
$0.00
-0.00 -0.00% today
Price History
Not enough data
Key Stats
Market Cap
14,334.124
Avg Volume
0
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
0.00
P/S Ratio
0.04
EV/EBITDA
0.69
EV/Revenue
-7.46
Margins
Gross Margin 67.6%
Operating Margin (217.3%)
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Revenue Growth (YoY)
9064.3%
Return on Equity
(28.1%)
Return on Assets
(15.9%)
Liquidity & Leverage
Current Ratio
0.73
Quick Ratio
0.53
Debt / Equity
0.01
Total Cash
2.40M
Total Debt
150,859
About
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
www.abattis.com